Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 13/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 13/20 | 0.58 |
| ▸ | RORC | P51449 | 3/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.51 |
| ▸ | RORA | P35398 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.51 |
| ▸ | MLYCD | O95822 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131990 | 0.89 | NR1H2 (0.68) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| Water SCHEMBL1684070 | 0.86 | NR1H2 (0.65) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL9621271 | 0.81 | NR1H2 (0.60) | NR1H2NR1H3RORCMLYCDSMN1; SMN2 | |
| SCHEMBL24901413 | 0.81 | NR1H2 (0.61) | NR1H2NR1H3RORCMLYCDSMN1; SMN2 | |
| SCHEMBL6808538 | 0.79 | ESR1 (0.61) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL1516045 | 0.79 | ESR1 (0.61) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL5314331 | 0.78 | RORC (0.79) | RORCSMN1; SMN2RAB9A | |
| SCHEMBL20149020 | 0.78 | NR1H2 (0.45) | NR1H2NR1H3RORCNR1I2RORA | |
| SCHEMBL20148977 | 0.78 | RORC (0.46) | NR1H2NR1H3RORCNR1I2 | |
| SCHEMBL128398 | 0.77 | NR1H2 (0.56) | NR1H2NR1H3MLYCDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1050833-A | — | — | None | — | — | JP | disclosed |
| US-11785845-B2 | Composition | FUJIFILM CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20230023593-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20230019681-A1 | POSITIVE RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20220045283-A1 | COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-02-10 | — | — | US | disclosed |
| US-6114345-A | Phenylsubstituted 4-azasteroid fluoroderivatives | PHARMACIA & UPJOHN, S.P.A. (IT) | 2000-09-05 | — | — | US | disclosed |
| EP-0793671-B1 | PHENYLSUBSTITUTED 4-AZASTEROID FLUORODERIVATIVES | PHARMACIA & UPJOHN SPA (IT) | 2000-02-09 | — | — | EP | disclosed |
| US-5922728-A | N-(PHENYLPERFLUOROALKYL)-3-OXO-4-AZA-5ALPHA-(ANDROSTANE OR ANDROST-1-ENE)-17BETA-CARBOXAMIDE DERIVATIVES, METHODS OF SYNTHESIZING THEM AND THEIR USE FOR TREATING PROSTATIC HYPERPLASIA | PHARMACIA & UPJOHN, S.P.A. (IT) | 1999-07-13 | — | — | US | disclosed |
| US-5827611-A | Multilayered thermoplastic article with special properties | HOECHST CELANESE CORP (US) | 1998-10-27 | — | — | US | disclosed |
| EP-0793671-A1 | PHENYLSUBSTITUTED 4-AZASTEROID FLUORODERIVATIVES | PHARMACIA & UPJOHN S.p.A. (IT) | 1997-09-10 | — | — | EP | disclosed |
| US-5175790-A | Waveguides for long distance transmission, high temperature continuous use | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0467935-A1 | TRANSPARENT THERMOPLASTIC MOULDING MATERIAL CONSISTING OF ESTERS OF 2,3-DIFLUORACRYLIC ACID. | HOECHST AG (DE) | 1992-01-29 | — | — | EP | disclosed |
| CN-1010098-B | Process for preparing alpha-fluoroacrylate polymers | HOECHST AG (DE) | 1990-10-24 | — | — | CN | disclosed |
| WO-1990012040-A1 | TRANSPARENT THERMOPLASTIC MOULDING MATERIAL CONSISTING OF ESTERS OF 2,3-DIFLUORACRYLIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-10-18 | — | — | WO | disclosed |
| EP-0203462-B1 | ALPHA-FLUOROACRYLIC-ACID ESTERS AND THEIR POLYMERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-01 | — | — | EP | disclosed |
| CN-1006380-B | Preparation method of alpha-fluoroacrylate and polymer thereof | HOECHST AG (DE) | 1990-01-10 | — | — | CN | disclosed |
| CN-1036209-A | Process for preparing alpha-fluoroacrylate polymers | HOECHST AG (DE) | 1989-10-11 | — | — | CN | disclosed |
| JP-S6450833-A | PRODUCTION OF 2,2-BIS(4-FLUOROPHENYL)HEXAFLUOROPROPANE | CENTRAL GLASS CO LTD | 1989-02-27 | — | — | JP | disclosed |
| CN-86103531-A | Alpha-fluoroacrylates and polymers thereof | — | 1987-01-28 | — | — | CN | disclosed |
| EP-0203462-A2 | Alpha-fluoroacrylic-acid esters and their polymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220045283-A1 | COMPOSITION | ADH1A, ADH1C, SLC19A2 | NR1H2 794/4885NR1H3 515/4885RORC 2360/4885 |
| US-11785845-B2 | Composition | ADH1A, ADH1C, SLC19A2 | NR1H2 794/4885NR1H3 515/4885RORC 2360/4885 |
| US-20230023593-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | HNRNPU, EWSR1, HNRNPR | NR1H2 3896/4885NR1H3 3340/4885RORC 3434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.